Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy

AIDS Research and Human Retroviruses

Volumn 25, Issue 8, 2009, Pages 765-769

  Garvey, Lucy J ^a,b   Yerrakalva, Dharani ^a   Winston, Alan ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; MEMORY; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; NONHUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COGNITION DISORDERS; COMPUTERS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; QUESTIONNAIRES; VIRAL LOAD;

EID: 70349259528     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0292     Document Type: Article

References (36)

1. Ho DD, Rota TR, Schooley RT, et al.: Isolation of HTLV-III from cerebrospinal fluid sand neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985;313(24):1493-1497.
2. Navia BA, Jordon BD, and Price RW: The AIDS dementia complex: I. Clinical features. Ann Neurol 1986;19(6):517-524.
3. McArthur JC, Hoover JR, et al.: Dementia in AIDS patients: Incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 1993;43(11):2245-2252.
4. Bhaskaran K, Mussini C, et al.: Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol 2008;63(2):213-221.
5. McArthur JC, McDermott MP, McClernon D, et al.: Attenuated central nervous system infection in advanced HIV=AIDS with combination antiretroviral therapy. Arch Neurol 2004;61(11):1687-1696.
6. Cherner M, Cysique L, Heaton R, et al.: Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. J NeuroVirol 2007;13:23-28.
7. Heaton RK, Grant I, et al.: Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive=motor disorder. American Academy of Neurology. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Neurology 1996;47:1247-1253.
8. Janssen RS, Cornblath DR, Epstein LG, et al.: Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection. Neurology 1991;41:778-785.
9. Antinori A, Arendt G, Becker JT, et al.: Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007;69(18):1789-1799.
10. Tozzi V, Balestra P, Galgani S, Narciso P, Sampaolesi A, Antinori A, et al.: Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years. J Acquir Immune Defic Syndr 2001;28(1):19-27.
11. Robertson KR, Robertson WT, Ford S, Watson D, Fiscus S, Harp AG, et al.: Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr 2004;36(1):562-566.
12. Cohen RA, Boland R, Paul R, Tashima KT, Schoenbaum EE, et al.: Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS 2001;15(3):341-345.
13. Tozzi V, Balestra P, Galgani S, Narciso P, Ferri F, Sebastiani G, et al.: Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS 1999;13(14):1889-1897.
14. Robertson KR, Smurzynski M, Parsons TD, et al.: The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 2007;21(14):1915-1921.
15. Dore GJ, Corrella PK, Lia Y, et al.: Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 1999;13:1249-1253
16. Dore GJ, McDonalda A, Corrella PK, et al.: Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003; 17(10):1539-1545.
17. Munoz-Moreno JA, Fumaz CR, Ferrer MJ, et al.: Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients. AIDS Res Hum Retroviruses 2008;24(10):1301-1307.
18. Cole MA, Margolick JB, Cox C, et al.: Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals. Neurology 2007;69(24):2213-2220.
19. Tozzi V, Balestra P, Bellagamba R, et al.: Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment prevalence and risk factors. J Acquir Immune Defic Syndr 2007;45:174-182. (Pubitemid 46869810)
20. Albert SM, Weber C, and Todak G: An observed performance test of medication management ability in HIV: Relation to neuropsychological status and adherence outcomes. AIDS Behav 1999;3:121-128.
21. Farinpour R, Miller EN, Satz P, et al.: Psychosocial risk factors of HIV morbidity and mortality: Findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol 2003;25(5):654-670.
22. Collie A, Darby D, and Maruff P: Computerised cognitive assessment of athletes with sports related head injury. Br J Sports Med 2001;35:297-302.
23. Collie A, Darby DG, Falleti MG, et al.: Determining the extent of cognitive change after coronary surgery: A review of statistical procedures. Ann Thorac Surg 2002;73:2005-2011.
24. Mollica CM, Maruff P, et al.: Repeated assessment of cognition in children and the measurement of performance change. Child Neuropsychol 2005;11:303-310.
25. Cysique LA, Maruff P, Darby D, and Brew BJ: The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol 2006;21(2):185-194.
26. Wilkie FL, Goodkin K, van Zuilen MH, Tyll MD, et al.: Cognitive effects of HIV-1 infection. CNS Spectr 2000;5(5):33-51.
27. Stout JC, Salmon DP, et al.: Decline in working memory associated with HIV infection. HNRC Group. Psychol Med 1995;25(6):1221-1232.
28. Carey CL, Woods SP, et al.: Prospective memory in HIV-1 infection. J Clin Exp Neuropsychol 2006;28(4):536-548.
29. Woods S P, Iudicello JE, Moran LM, et al.: HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology 2008;22(1):110-117.
30. Letendre S, Marquie-Beck J, et al.: Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008;65(1):65-70.
31. Crawford JR, Smith G, Maylor EA, et al.: The Prospective and Retrospective Memory Questionnaire (PRMQ): Normative data and latent structure in a large non-clinical sample. Memory 2003;11(3):261-275.
32. Maruff P: Validity of the CogState computerized test battery: Sensitivity to mild traumatic brain injury, mild cognitive impairment, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol (in press).
33. Langford TD, et al.: Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol 2003;13(2):195-210.
34. Sharer LR and Cho ES: Neuropathology of HIV infection: Adults versus children. Prog AIDS Pathol 1989;1:131-141.
35. Melrose RJ, Tinaz S, Castelo JM, et al.: Compromised frontostriatal functioning in HIV: An fMRI investigation of semantic event sequencing. Behav Brain Res 2008;188(2):337-347.
36. Crawford JR, Henry JD, Ward AL, et al.: The Prospective and Retrospective Memory Questionnaire (PRMQ): Latent structure, normative data and discrepancy analysis for proxy-ratings. Br J Clin Psychol 2006;45:83-104.